Researchers at The University of Texas MD Anderson Cancer Center have performed a comprehensive evaluation of five artificial intelligence (AI) models trained on genomic sequences, known as DNA ...
GENEVA & PALO ALTO, Calif.--(BUSINESS WIRE)--In a bold move to redefine the future of human performance and wellbeing, MAXIOM Labs and DNAthlete AG today announced a strategic partnership to combine ...
A novel, blood-based test developed using fragmentomic features of cell-free DNA (cfDNA) detects colorectal cancer (CRC) with a 90.4% sensitivity and shows consistent performance across stages and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results